Serum globulins contribute to the discrepancies observed between the bromocresol green and bromocresol purple assays of serum albumin concentration

被引:1
作者
Xu, Y. [1 ]
Wang, L. [1 ]
Wang, J. [1 ]
Liang, H. [1 ]
Jiang, X. [1 ]
机构
[1] Harbin Med Coll, Dept Clin Labs, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China
关键词
Bromcresol green; Bromcresol purple; Serum albumin; Serum globulins; BROMCRESOL PURPLE; HEMODIALYSIS-PATIENTS; DYE-BINDING; PROTEIN; IMMUNOTURBIDIMETRY; ELECTROPHORESIS; IMMUNOASSAY; DIALYSIS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The bromocresol green (BCG) and bromocresol purple (BCP) assays often yield discordant serum albumin results. This study seeks to test the hypothesis that bias in albumin results are influenced by the concentration of serum globulin subtypes. The concentrations of serum albumin, alpha 1-globulin, alpha 2-globulin, beta-globulin and gamma-globulin are determined in 197 human serum specimens by total serum protein quantification and protein electrophoresis, and by the BCG and BCP assays. The influence of globulins on albumin measurement is validated with protein mixtures of albumin and globulins. The BCG assay bias was directly proportional to the concentrations of alpha 1-globulin and alpha 2-globulin, and inversely correlated with the concentrations of beta-globulin and gamma-globulin (r(2)=0.793). The BCP assay bias was inversely proportional to the concentration of alpha 1-globulin and alpha 2-globulin (r(2)=0.464) but not related to the concentrations of beta-globulin or gamma-globulin. Among the 197 study participants, those with nephrotic syndrome had a significantly higher level of alpha 2-globulin compared to those in other categories. Thus, the authors conclude that serum globulins contribute to the bias seen in the BCG and BCP assays, with the greatest effects observed for alpha-globulin on the BCG assay where higher concentrations contributed to a higher bias.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 24 条
  • [1] BEYER C, 1994, CLIN CHEM, V40, P844
  • [2] SERUM-ALBUMIN CONCENTRATION-RELATED HEALTH-CARE FINANCING ADMINISTRATION QUALITY ASSURANCE CRITERION IS METHOD-DEPENDENT - REVISION IS NECESSARY
    BLAGG, CR
    LIEDTKE, RJ
    BATJER, JD
    RACOOSIN, B
    SAWYER, TK
    WICK, MJ
    LAWSON, L
    WILKENS, K
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (02) : 138 - 144
  • [3] BUSH V, 1987, CLIN CHEM, V33, P821
  • [4] Albumin as an outcome measure in haemodialysis in patients: the effect of variation in assay method
    Carfray, A
    Patel, K
    Whitaker, P
    Garrick, P
    Griffiths, GJ
    Warwick, GL
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (11) : 1819 - 1822
  • [5] Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease
    Clase, CM
    St Pierre, MW
    Churchill, DN
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (09) : 1925 - 1929
  • [6] Measurement of serum albumin by capillary zone electrophoresis, bromocresol green, bromocresol purple, and immunoassay methods
    Duly, EB
    Grimason, S
    Grimason, P
    Barnes, G
    Trinick, TR
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (10) : 780 - 781
  • [7] GUO J, 2000, CHINESE J LAB MED, V23, P22
  • [8] GUSTAFSSON JEC, 1976, CLIN CHEM, V22, P616
  • [9] Comparison of methods for measuring albumin in peritoneal dialysis and hemodialysis patients
    Joseph, R
    Tria, L
    Mossey, RT
    Bellucci, AG
    Mailloux, LU
    Vernace, MA
    Miller, I
    Wilkes, BM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (04) : 566 - 572
  • [10] Lyon AW, 1998, CLIN CHEM, V44, P2365